CN Stock MarketDetailed Quotes
002435 Changjiang Runfa Health Industry
- 0.37
- 0.000.00%
Market Closed Jul 26 09:30 CST
457.31MMarket Cap-546P/E (TTM)
0.00High0.00Low0lotVolume0.00Open0.37Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)1.24BShares4.9552wk High0.12P/B444.94MFloat Cap0.3752wk Low0.39Limit Up1.20BShs Float9.89Historical High0.35Limit Down0.00%Amplitude0.37Historical Low--Dividend TTM--Avg Price0lotAsk--Div YieldTTM100Lot Size0lotBid
Changjiang Runfa Health Industry Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -24.42%660.21M | -6.67%3.24B | -7.95%2.53B | -2.80%1.75B | -3.52%873.54M | -20.60%3.47B | -18.47%2.75B | -18.17%1.8B | -13.44%905.41M | 3.05%4.37B |
| Operating revenue | -24.42%660.21M | -6.67%3.24B | -7.95%2.53B | -2.80%1.75B | -3.52%873.54M | -20.60%3.47B | -18.47%2.75B | -18.17%1.8B | -13.44%905.41M | 3.05%4.37B |
| Other operating revenue | ---- | 3.93%23.84M | ---- | -13.31%8.3M | ---- | -16.91%22.94M | ---- | -22.77%9.57M | ---- | 137.57%27.61M |
| Total operating cost | -15.12%672.49M | -0.36%3.39B | -7.36%2.46B | -4.02%1.66B | -7.05%792.27M | -19.03%3.4B | -16.06%2.66B | -14.74%1.73B | -7.99%852.36M | 5.66%4.2B |
| Operating cost | -6.62%486.36M | -6.58%2.16B | -8.78%1.68B | -6.09%1.12B | -6.76%520.81M | -5.41%2.31B | 2.63%1.84B | 12.23%1.19B | 24.34%558.55M | 31.77%2.44B |
| Operating tax surcharges | -38.50%5.31M | 4.84%30.23M | 10.63%23.13M | 17.72%16.05M | 45.00%8.63M | -18.42%28.84M | -14.16%20.91M | -14.05%13.64M | -35.16%5.95M | 1.53%35.35M |
| Operating expense | -59.45%74.51M | 2.65%737.87M | -5.67%503.26M | 2.45%357.84M | -9.98%183.73M | -48.36%718.81M | -52.11%533.49M | -55.69%349.27M | -47.44%204.11M | -19.98%1.39B |
| Administration expense | 2.27%48.96M | -7.20%206.82M | -21.46%143.39M | -17.86%93.11M | -11.15%47.87M | 14.98%222.87M | 20.41%182.58M | 14.74%113.36M | 18.10%53.88M | -12.49%193.83M |
| Financial expense | 5.64%22.36M | 28.05%89.7M | 29.35%67.42M | 28.31%44.18M | 15.46%21.17M | 11.23%70.05M | 20.32%52.12M | 17.74%34.43M | 29.71%18.33M | 15.84%62.98M |
| -Interest expense (Financial expense) | 3.46%22.98M | 24.76%92.23M | 39.41%67.65M | 22.30%43.8M | 21.16%22.21M | 8.20%73.93M | 2.11%48.53M | 9.53%35.82M | 16.43%18.33M | 7.91%68.32M |
| -Interest Income (Financial expense) | 26.45%-882.95K | -19.71%-3.5M | 58.89%-2.11M | 17.72%-1.42M | -12.69%-1.2M | 60.10%-2.93M | 26.72%-5.14M | 63.80%-1.73M | 51.21%-1.07M | 36.84%-7.33M |
| Research and development | 247.97%34.99M | 241.73%163.77M | 57.18%48.11M | 12.81%25.5M | -12.76%10.06M | -32.51%47.92M | -26.21%30.61M | -25.01%22.6M | -41.80%11.53M | 3.32%71.01M |
| Credit Impairment Loss | -100.66%-4.6M | -128.49%-9.67M | -114.91%-4.94M | -107.70%-3M | -251.22%-2.29M | 954.50%33.95M | 1,069.43%33.16M | 7,968.60%38.96M | 230.30%1.52M | 110.15%3.22M |
| Asset Impairment Loss | 44.30%-8.19M | -892.15%-673.8M | -14.57%-31.52M | 4.08%-25.23M | -79.02%-14.7M | 91.22%-67.91M | 13.31%-27.51M | -36.85%-26.31M | 57.85%-8.21M | -1,281.72%-773.85M |
| Other net revenue | 132.45%3.38M | -4,491.48%-635.43M | -66.40%10.33M | -114.36%-4.78M | -285.27%-10.41M | 102.01%14.47M | 248.78%30.74M | 558.50%33.32M | 143.18%5.62M | -1,715.25%-720.84M |
| Fair value change income | -171.15%-248.99K | 64.70%248.57K | -81.84%921.99K | -96.79%106K | -86.22%349.98K | 113.39%150.92K | 580.88%5.08M | 231.21%3.31M | -6.80%2.54M | -160.55%-1.13M |
| Invest income | 534.23%3.05M | -9,738.22%-7.33M | 132.25%601.29K | 112.98%421.18K | 293.15%481.66K | -99.43%76.04K | -117.56%-1.86M | -145.75%-3.25M | -120.34%-249.36K | 487.91%13.24M |
| -Including: Investment income associates | ---- | -222.68%-19.23M | -29.44%-4.2M | 10.95%-2.81M | -2.56%-1.34M | -2,345.34%-5.96M | ---3.24M | -430.02%-3.16M | -561.84%-1.31M | 86.79%-243.68K |
| Asset deal income | ---396.57 | -44.03%697.65K | -239.12%-73.35K | --0 | ---- | 473.36%1.25M | -115.96%-21.63K | --0 | --0 | 172.79%217.41K |
| Other revenue | 132.24%13.36M | 15.90%54.43M | 107.09%45.34M | 11.23%22.92M | -42.58%5.75M | 25.36%46.96M | 356.26%21.9M | 371.49%20.61M | 171.97%10.02M | -72.09%37.46M |
| Operating profit | -112.56%-8.9M | -1,016.06%-783.72M | -34.69%81.88M | -18.32%85.14M | 20.78%70.85M | 115.61%85.55M | -33.73%125.36M | -36.58%104.24M | -44.98%58.66M | -275.12%-548.13M |
| Add:Non operating Income | 36.59%437.29K | -11.32%5.08M | -41.34%2.85M | 5.16%1.86M | -97.55%320.14K | -96.12%5.73M | -96.63%4.86M | -77.68%1.77M | 2,630.82%13.07M | 12,126.71%147.51M |
| Less:Non operating expense | -50.63%606.94K | -79.83%5.02M | 313.94%14.9M | 323.64%7.51M | 8.23%1.23M | 279.14%24.9M | 310.39%3.6M | 615.08%1.77M | -77.53%1.14M | -71.66%6.57M |
| Total profit | -112.97%-9.07M | -1,280.62%-783.66M | -44.85%69.83M | -23.74%79.49M | -0.92%69.94M | 116.30%66.38M | -61.94%126.63M | -39.41%104.23M | -30.83%70.59M | -239.91%-407.18M |
| Less:Income tax cost | -34.70%7.11M | -2.93%24.31M | -26.04%21.7M | -30.84%15.42M | -19.53%10.89M | 189.18%25.04M | 76.16%29.34M | 8.18%22.3M | -3.07%13.53M | -81.65%8.66M |
| Net profit | SL-16.18M | SL-807.97M | -50.52%48.13M | -21.80%64.07M | 3.50%59.05M | FLtoP41.33M | -69.22%97.28M | -45.89%81.94M | -35.23%57.06M | SL-415.84M |
| Net profit from continuing operation | -127.40%-16.18M | -2,054.77%-807.97M | -50.52%48.13M | -21.80%64.07M | 3.50%59.05M | 109.94%41.33M | -69.22%97.28M | -45.89%81.94M | -35.23%57.06M | -270.54%-415.84M |
| Less:Minority Profit | -461.96%-6.12M | -72.86%-41.24M | -89.51%-19.04M | -11.51%-10.05M | 78.49%-1.09M | -735.36%-23.86M | -549.47%-10.04M | -1,217.19%-9.02M | -12,895.12%-5.06M | 25.80%-2.86M |
| Net profit of parent company owners | -116.74%-10.07M | -1,276.14%-766.73M | -37.42%67.17M | -18.50%74.13M | -3.18%60.14M | 115.79%65.19M | -66.21%107.33M | -40.20%90.95M | -29.51%62.12M | -266.74%-412.99M |
| Earning per share | ||||||||||
| Basic earning per share | -116.63%-0.0081 | -1,277.04%-0.6203 | -37.44%0.0543 | -18.48%0.06 | -3.18%0.0487 | 115.77%0.0527 | -66.23%0.0868 | -40.21%0.0736 | -29.45%0.0503 | -266.72%-0.3341 |
| Diluted earning per share | -116.63%-0.0081 | -1,277.04%-0.6203 | -37.44%0.0543 | -18.48%0.06 | -3.18%0.0487 | 115.77%0.0527 | -66.23%0.0868 | -40.21%0.0736 | -29.45%0.0503 | -266.72%-0.3341 |
| Other composite income | 101.77%8.64K | -82.80%347.75K | -73.42%627.67K | -29.59%740.42K | -194.23%-487.68K | 101.88%2.02M | 1,062.44%2.36M | 488.58%1.05M | -279.62%-165.75K | -64.59%-107.37M |
| Other composite income of parent company owners | 101.77%8.64K | -82.80%347.75K | -73.42%627.67K | -29.59%740.42K | -194.23%-487.68K | 101.88%2.02M | 1,062.44%2.36M | 488.58%1.05M | -279.62%-165.75K | -64.59%-107.37M |
| Total composite income | -127.62%-16.17M | -1,962.82%-807.62M | -51.07%48.76M | -21.90%64.81M | 2.94%58.57M | 108.29%43.35M | -68.45%99.65M | -45.10%82.99M | -35.48%56.89M | -392.95%-523.21M |
| Total composite income of parent company owners | -116.86%-10.06M | -1,240.25%-766.38M | -38.19%67.8M | -18.63%74.87M | -3.71%59.65M | 112.92%67.21M | -65.44%109.69M | -39.40%92M | -29.78%61.95M | -385.20%-520.36M |
| Total composite income of minority owners | -461.96%-6.12M | -72.86%-41.24M | -89.51%-19.04M | -11.51%-10.05M | 78.49%-1.09M | -735.36%-23.86M | -549.47%-10.04M | -1,217.19%-9.02M | -12,895.12%-5.06M | 25.80%-2.86M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Adverse Opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Hwashin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Hwashin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Hwashin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg